Reaction
Telangiectasia reporting signals
As of the last recalculation, Telangiectasia appears in 940 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is ADO-TRASTUZUMAB EMTANSINE (PRR 45.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ado-Trastuzumab Emtansine | 17 | 45.5 | 45.5 |
| Epoprostenol | 14 | 24.0 | 24.0 |
| Nintedanib | 27 | 19.6 | 19.6 |
| Vismodegib | 6 | 15.0 | 15.0 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 15 | 14.4 | 14.4 |
| Sildenafil Powder, | 21 | 13.3 | 13.3 |
| Triamcinolone Acetonide | 16 | 11.6 | 11.7 |
| Macitentan | 32 | 10.6 | 10.6 |
| Selexipag | 12 | 10.4 | 10.4 |
| Tadalafil | 43 | 9.9 | 9.9 |
| Bosentan | 22 | 9.9 | 9.9 |